{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:01:47Z","timestamp":1787828507706,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04540-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:58:42Z","timestamp":1768989522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differentiated high-grade thyroid carcinoma (DHGTC): clinicopathological analysis of a new entity in a chilean center"],"prefix":"10.1007","volume":"91","author":[{"given":"Marl\u00edn","family":"Sol\u00f3rzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Mosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Vi\u00f1ambres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"H Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Jaimovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonieta","family":"Solar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"M Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"18","key":"4540_CR1","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"L Davies","year":"2006","unstructured":"L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the united States, 1973\u20132002. JAMA 295(18), 2164 (2006)","journal-title":"JAMA"},{"issue":"4","key":"4540_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3803\/EnM.2024.1927","volume":"39","author":"JY Kim","year":"2024","unstructured":"J.Y. Kim, J.K. Myung, S. Kim, K. Tae, Y.Y. Choi, S.J. Lee, Prognosis of poorly differentiated thyroid carcinoma: A systematic review and Meta-Analysis. Endocrinol. Metab. 39(4), 590\u2013602 (2024)","journal-title":"Endocrinol. Metab."},{"issue":"6","key":"4540_CR3","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/cncr.21739","volume":"106","author":"D Hiltzik","year":"2006","unstructured":"D. Hiltzik, D.L. Carlson, R.M. Tuttle, S. Chuai, N. Ishill, A. Shaha et al., Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 106(6), 1286\u20131295 (2006)","journal-title":"Cancer"},{"issue":"8","key":"4540_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"M. Volante, P. Collini, Y.E. Nikiforov, A. Sakamoto, K. Kakudo, R. Katoh et al., Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am. J. Surg. Pathol. 31(8), 1256\u20131264 (2007)","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"4540_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/modpathol.2010.117","volume":"23","author":"S. Asioli","year":"2010","unstructured":"S. Asioli, L.A. Erickson, A. Righi, L. Jin, M. Volante, S. Jenkins et al., Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod. Pathol. 23(9), 1269\u20131278 (2010)","journal-title":"Mod. Pathol."},{"issue":"9","key":"4540_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00268-019-05028-5","volume":"15","author":"J. Akaishi","year":"2019","unstructured":"J. Akaishi, T. Kondo, K. Sugino, Y. Ogimi, C. Masaki, K.Y. Hames et al., Prognostic impact of the Turin criteria in poorly differentiated thyroid carcinoma. World J. Surg. 15(9), 2235\u20132244 (2019)","journal-title":"World J. Surg."},{"issue":"2","key":"4540_CR7","doi-asserted-by":"publisher","first-page":"e220293","DOI":"10.1530\/ERC-22-0293","volume":"30","author":"C Christofer Juhlin","year":"2023","unstructured":"C. Christofer Juhlin, O. Mete, Z.W. Baloch, The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr. Relat. Cancer. 30(2), e220293 (2023)","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"4540_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/thy.2023.0350","volume":"34","author":"AM Poma","year":"2024","unstructured":"A.M. Poma, E. Macerola, R.A. Ghossein, G. Tallini, F. Basolo, Prevalence of differentiated High-Grade thyroid carcinoma among Well-Differentiated tumors: A systematic review and Meta-Analysis. Thyroid\u00ae. 34(3), 314\u2013323 (2024)","journal-title":"Thyroid\u00ae"},{"issue":"6","key":"4540_CR9","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.3390\/curroncol31060252","volume":"9","author":"A.S. Harahap","year":"2024","unstructured":"A.S. Harahap, R.S. Roren, S. Imtiyaz, A comprehensive review and insights into the new entity of differentiated High-Grade thyroid carcinoma. Curr. Oncol. 9(6), 3311\u20133328 (2024)","journal-title":"Curr. Oncol."},{"issue":"8","key":"4540_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cncy.22874","volume":"132","author":"VF Torous","year":"2024","unstructured":"V.F. Torous, T. Jitpasutham, Z. Baloch, R.L. Cantley, D.A. Kerr, X. Liu et al., Cytologic features of differentiated high-grade thyroid carcinoma: A multi\u2010institutional study of 40 cases. Cancer Cytopathol. 132(8), 525\u2013536 (2024)","journal-title":"Cancer Cytopathol."},{"issue":"7","key":"4540_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/his.15157","volume":"84","author":"R. Ghossein","year":"2024","unstructured":"R. Ghossein, N. Katabi, S. Dogan, A.R. Shaha, R.M. Tuttle, J.A. Fagin et al., Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high\u2010grade differentiated thyroid carcinoma tall cell phenotype (HGDTC\u2010TC) have different clinical behaviour: a retrospective study of 1456 patients. Histopathology. 84(7), 1130\u20131138 (2024)","journal-title":"Histopathology"},{"issue":"1","key":"4540_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al., 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid Off J. Am. Thyroid Assoc. 26(1), 1\u2013133 (2016)","journal-title":"Thyroid Off J. Am. Thyroid Assoc."},{"issue":"8","key":"4540_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"M.D. Ringel, J.A. Sosa, Z. Baloch, L. Bischoff, G. Bloom, G.A. Brent et al., 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid Off J. Am. Thyroid Assoc. 35(8), 841\u2013985 (2025)","journal-title":"Thyroid Off J. Am. Thyroid Assoc."},{"issue":"03","key":"4540_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0043-1771286","volume":"22","author":"J. Paudel","year":"2023","unstructured":"J. Paudel, Establishing a cutoff serum thyroglobulin value for the diagnosis and management of Well-Differentiated thyroid cancer. World J. Nucl. Med. 22(03), 208\u2013216 (2023)","journal-title":"World J. Nucl. Med."},{"key":"4540_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.humpath.2024.01.002","volume":"144","author":"I Tondi Resta","year":"2024","unstructured":"I. Tondi Resta, M.A. Gubbiotti, K.T. Montone, V.A. Livolsi, Z.W. Baloch, Differentiated high grade thyroid carcinomas: diagnostic consideration and clinical features. Hum. Pathol. 144, 53\u201360 (2024)","journal-title":"Hum. Pathol."},{"issue":"1","key":"4540_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAP.0000000000000380","volume":"30","author":"B Xu","year":"2023","unstructured":"B. Xu, R.A. Ghossein, Advances in thyroid pathology: high grade follicular Cell-derived thyroid carcinoma and anaplastic thyroid carcinoma. Adv. Anat. Pathol. 30(1), 3\u201310 (2023)","journal-title":"Adv. Anat. Pathol."},{"issue":"2","key":"4540_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12022-023-09770-4","volume":"34","author":"L.D.R. Thompson","year":"2023","unstructured":"L.D.R. Thompson, High grade differentiated follicular Cell-Derived thyroid carcinoma versus poorly differentiated thyroid carcinoma: A clinicopathologic analysis of 41 cases. Endocr. Pathol. 34(2), 234\u2013246 (2023)","journal-title":"Endocr. Pathol."},{"issue":"6","key":"4540_CR18","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00405-017-4527-6","volume":"274","author":"D.B. Skansing","year":"2017","unstructured":"D.B. Skansing, S.C. Londero, P. Asschenfeldt, S.R. Larsen, C. Godballe, Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up. Eur. Arch. Otorhinolaryngol. 274(6), 2541\u20132548 (2017)","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"3","key":"4540_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12022-023-09778-w","volume":"34","author":"S.I. Jeong","year":"2023","unstructured":"S.I. Jeong, W. Kim, H.W. Yu, J.Y. Choi, C.H. Ahn, J.H. Moon et al., Incidence and clinicopathological features of differentiated High-Grade thyroid carcinomas: an institutional experience. Endocr. Pathol. 34(3), 287\u2013297 (2023)","journal-title":"Endocr. Pathol."},{"issue":"6","key":"4540_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4132\/jptm.2024.07.29","volume":"58","author":"JY Pyo","year":"2024","unstructured":"J.Y. Pyo, Y.J. Cha, S. Hong, TERT mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer. J. Pathol. Transl Med. 58(6), 310\u2013320 (2024)","journal-title":"J. Pathol. Transl Med."},{"key":"4540_CR21","doi-asserted-by":"crossref","unstructured":"E. Robenshtok, G. Bachar, A. Ritter, Approach to the patient with thyroid cancer: selection and management of candidates for lobectomy. J. Clin. Endocrinol. Metab. (2025)","DOI":"10.1210\/clinem\/dgae903"},{"issue":"2","key":"4540_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/thy.2024.0499","volume":"35","author":"DW Scholfield","year":"2025","unstructured":"D.W. Scholfield, B. Xu, H. Levyn, A. Eagan, A.R. Shaha, J.P. Shah et al., High-Grade follicular Cell-Derived Non-Anaplastic thyroid carcinoma: correlating extent of invasion and mutation profile with oncologic outcome. Thyroid\u00ae. 35(2), 153\u2013165 (2025)","journal-title":"Thyroid\u00ae"},{"issue":"1","key":"4540_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S2213-8587(18)30306-1","volume":"7","author":"HM Dehbi","year":"2019","unstructured":"H.M. Dehbi, U. Mallick, J. Wadsley, K. Newbold, C. Harmer, A. Hackshaw, Recurrence after low-dose radioiodine ablation and Recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes Endocrinol. 7(1), 44\u201351 (2019)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"4540_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/thy.2007.0061","volume":"17","author":"R.A. Ghossein","year":"2007","unstructured":"R.A. Ghossein, R. Leboeuf, K.N. Patel, M. Rivera, N. Katabi, D.L. Carlson et al., Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid. 17(7), 655\u2013661 (2007)","journal-title":"Thyroid"},{"issue":"3","key":"4540_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.SLA.0000055273.58908.19","volume":"237","author":"N Wada","year":"2003","unstructured":"N. Wada, Q.Y. Duh, K. Sugino, H. Iwasaki, K. Kameyama, T. Mimura et al., Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and Recurrence, and optimal strategy for neck dissection. Ann. Surg. 237(3), 399\u2013407 (2003)","journal-title":"Ann. Surg."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04540-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04540-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:58:43Z","timestamp":1768989523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04540-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4540"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04540-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marl\u00edn Sol\u00f3rzano has nothing to disclose. Ignacio Fuentes has nothing to disclose. Jos\u00e9 Miguel Gonz\u00e1lez has nothing to disclose. Nicole Lustig has nothing to disclose. Lorena Mosso has nothing to disclose. Joel Falc\u00f3n has nothing to disclose. Catalina Ruiz has nothing to disclose. Joaqu\u00edn Vi\u00f1ambres has nothing to disclose. Rodolfo Cabello has nothing to disclose. Hern\u00e1n E Gonz\u00e1lez holds shares in GeneproDx. Pablo H Montero has nothing to disclose. Antonieta Solar has nothing to disclose. Francisco Cruz has nothing to disclose. Jose M Dominguez has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"43"}}